{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T17:55:11Z","timestamp":1768672511560,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.neurol.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T12:04:58Z","timestamp":1472040298000},"page":"455-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neurometabolic disorders are treatable causes of dystonia"],"prefix":"10.1016","volume":"172","author":[{"given":"A.","family":"Kuiper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Eggink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0355","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0360","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.25527","article-title":"The anatomical basis of dystonia: current view using neuroimaging","volume":"28","author":"Leh\u00e9ricy","year":"2013","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.011_bib0365","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s004150070094","article-title":"A prevalence study of primary dystonia in eight European countries","volume":"247","author":"Epidemiology Study of Dystonia in Europe (EDSE) CG","year":"2000","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.011_bib0370","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13023-014-0177-6","article-title":"Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning","volume":"9","author":"Eggink","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0375","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejpn.2009.11.005","article-title":"Movement disorders in neuro-metabolic diseases","volume":"14","author":"Gouider-Khouja","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0380","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mds.25548","article-title":"Special concerns in defining, studying, and treating dystonia in children","volume":"28","author":"Mink","year":"2013","journal-title":"Mov Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2016.07.011_bib0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1468-1331.2010.03051.x","article-title":"Secondary dystonia\u00a0\u2013\u00a0Clinical clues and syndromic associations","volume":"17","author":"Schneider","year":"2010","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2016.07.011_bib0390","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/archdischild-2012-302840","article-title":"Neurodegenerative disorders and metabolic disease","volume":"98","author":"Pierre","year":"2013","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0395","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10545-009-1194-9","article-title":"Inborn errors of metabolism and motor disturbances in children","volume":"32","author":"Garc\u0131","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0400","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11910-014-0461-9","article-title":"Clinical spectrum of dopa-responsive dystonia and related disorders","volume":"14","author":"Lee","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0405","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11910-013-0342-7","article-title":"Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS)","volume":"13","author":"Pearson","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.011_bib0410","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dmcn.12339","article-title":"Status dystonicus: a practice guide","volume":"56","author":"Allen","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.neurol.2016.07.011_bib0415","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S1090-3798(15)30258-0","article-title":"Crossing barriers: the importance of a multidisciplinary approach to young-onset movement disorders","volume":"19","author":"Eggink","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neurol.2016.07.011_bib0420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5152\/TurkPediatriArs.2016.3080","article-title":"Neurological features and management of Wilson disease in children: an evaluation of 12 cases","author":"Kacar Bayram","year":"2016","journal-title":"T\u00fcrk Pediatr Ar\u015fivi"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0425","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/humu.22048","article-title":"Next-generation sequencing demands next-generation phenotyping","volume":"33","author":"Hennekam","year":"2012","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.011_bib0430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2014.254","article-title":"Genetic advances spark a revolution in dystonia phenotyping","volume":"11","author":"De Koning","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.011_bib0435","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1468-1331.2011.03649.x","article-title":"Treatment for dystonia in childhood","volume":"19","author":"Roubertie","year":"2012","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.011_bib0440","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00415-014-7250-x","article-title":"Paroxysmal exercise-induced dystonia due to GLUT1 mutation can be responsive to levodopa: a case report","volume":"261","author":"Baschieri","year":"2014","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0445","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2014-309106","article-title":"Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm","volume":"86","author":"van Egmond","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.011_bib0450","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10545-008-1007-6","article-title":"The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism","volume":"32","author":"Pons","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0455","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awq087","article-title":"Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis","volume":"133","author":"Willemsen","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0460","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pediatrneurol.2006.05.006","article-title":"Sepiapterin reductase deficiency: clinical presentation and evaluation of long-term therapy","volume":"35","author":"Echenne","year":"2006","journal-title":"Pediatr Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.011_bib0465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","article-title":"Monoamine neurotransmitter disorders\u00a0\u2013\u00a0clinical advances and future perspectives","volume":"11","author":"Ng","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.neurol.2016.07.011_bib0470","doi-asserted-by":"crossref","first-page":"S473","DOI":"10.1007\/s00247-015-3279-y","article-title":"Neurometabolic diseases of childhood","volume":"45","author":"Patay","year":"2015","journal-title":"Pediatr Radiol"},{"issue":"8","key":"10.1016\/j.neurol.2016.07.011_bib0475","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(11)70141-7","article-title":"The monoamine neurotransmitter disorders: an expanding range of neurological syndromes","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0480","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1203\/01.pdr.0000219387.79887.86","article-title":"Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency","volume":"59","author":"K\u00f6lker","year":"2006","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0485","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ymgme.2012.05.024","article-title":"Glutaric acidemia type 1: outcomes before and after expanded newborn screening","volume":"106","author":"Viau","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0490","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s10545-009-1189-6","article-title":"Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters","volume":"32","author":"H\u00f6rster","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2016.07.011_bib0495","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","article-title":"Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia","volume":"9","author":"Baumgartner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.neurol.2016.07.011_bib0500","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1212\/01.WNL.0000167428.12417.B2","article-title":"Late-onset neurologic disease in glutaryl-CoA dehydrogenase","volume":"64","author":"K\u00fclkens","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.07.011_bib0505","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/8904_2014_353","article-title":"Rare late-onset presentation of glutaric aciduria type I in a 16-year-old woman with a novel GCDH mutation","volume":"18","author":"Fraidakis","year":"2015","journal-title":"JIMD Rep"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0510","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10048-015-0456-y","article-title":"Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules","volume":"16","author":"Pierson","year":"2015","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurol.2016.07.011_bib0515","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13023-014-0197-2","article-title":"Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review","volume":"9","author":"Leach","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0520","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejrad.2012.12.006","article-title":"Basal ganglia lesions in children and adults","volume":"82","author":"Bekiesinska-Figatowska","year":"2013","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0705","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamaneurol.2016.0355","article-title":"Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease","volume":"73","author":"Martikainen","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2016.07.011_bib0530","series-title":"GeneReviews\u00ae [Internet]. 2015, Octo. Seattle: Gene Reviews","first-page":"1","article-title":"Nuclear gene-encoded Leigh syndrome","author":"Rahman","year":"2015"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.011_bib0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/brain\/awv342","article-title":"Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome","volume":"139","author":"Ortigoza-Escobar","year":"2016","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.neurol.2016.07.011_bib0540","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12311-012-0378-2","article-title":"Characterizing POLG ataxia: clinics, electrophysiology and imaging","author":"Synofzik","year":"2012","journal-title":"Cerebellum"},{"issue":"12","key":"10.1016\/j.neurol.2016.07.011_bib0545","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.24912","article-title":"Expanding spectrum of abnormal movements in MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes)","volume":"27","author":"Singmaneesakulchai","year":"2012","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0550","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-012-9465-2","article-title":"Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A>G mutation","volume":"35","author":"De Laat","year":"2012","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.011_bib0555","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1469-8749.2009.03541.x","article-title":"Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis","volume":"52","author":"Barnerias","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.011_bib0560","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0034-1399755","article-title":"Eyes on MEGDEL: distinctive basal ganglia involvement in dystonia deafness syndrome","volume":"46","author":"Wortmann","year":"2015","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0565","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.mito.2009.08.003","article-title":"Dystonia and deafness due to SUCLA2 defect; clinical course and biochemical markers in 16 children","volume":"9","author":"Morava","year":"2009","journal-title":"Mitochondrion"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0570","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/mds.25394","article-title":"The syndrome of deafness-dystonia: clinical and genetic heterogeneity","volume":"28","author":"Kojovic","year":"2013","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.011_bib0575","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00415-013-7159-9","article-title":"Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C disease","volume":"261","author":"Anheim","year":"2014","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.011_bib0580","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awl260","article-title":"The adult form of Niemann-Pick disease type C","volume":"130","author":"S\u00e9vin","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/01.NEU.0000245620.24603.1B","article-title":"Deep brain stimulation of the globus pallidus for generalized dystonia in GM1 type 3 gangliosidosis: technical case report","volume":"59","author":"Roze","year":"2006","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0590","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/0972-2327.160090","article-title":"Clinical and neuroradiological approach to fucosidosis in a child with atypical presentation","volume":"18","author":"Zubarioglu","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0595","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejpn.2014.02.005","article-title":"Late diagnosis of fucosidosis in a child with progressive fixed dystonia, bilateral pallidal lesions and red spots on the skin","volume":"18","author":"Gautschi","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.011_bib0600","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MD.0b013e318045a00e","article-title":"Wilson disease","volume":"86","author":"Taly","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.011_bib0605","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.25138","article-title":"Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder","volume":"27","author":"Stamelou","year":"2012","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0610","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11910-010-0136-0","article-title":"Rare causes of dystonia parkinsonism","volume":"10","author":"Schneider","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0615","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-014-9713-8","article-title":"X-linked creatine transporter deficiency: clinical aspects and pathophysiology","volume":"37","author":"van de Kamp","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.011_bib0620","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/01.wnl.0000234852.43688.bf","article-title":"GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis","volume":"67","author":"Mercimek-Mahmutoglu","year":"2006","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.neurol.2016.07.011_bib0625","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/mds.25206","article-title":"Myoclonus and dystonia in cerebrotendinous xanthomatosis","volume":"27","author":"Lagarde","year":"2012","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0630","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mds.25348","article-title":"Movement disorders in adult patients with classical galactosemia","volume":"28","author":"Rubio-Agusti","year":"2013","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0635","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mds.23709","article-title":"Nonmotor manifestations of dystonia: a systematic review","volume":"26","author":"Kuyper","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.011_bib0640","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JPD-130283","article-title":"Mental dysfunctions in dystonia-plus syndromes","volume":"4","author":"Sunga","year":"2014","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.neurol.2016.07.011_bib0645","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.parkreldis.2015.07.003","article-title":"Non-motor symptoms in genetically defined dystonia: homogenous groups require systematic assessment","volume":"21","author":"Peall","year":"2015","journal-title":"Park Relat Disord"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.011_bib0650","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mds.25552","article-title":"Medical treatment of dystonia","volume":"28","author":"Jankovic","year":"2013","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.011_bib0655","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpn.2015.09.007","article-title":"Gabapentin can significantly improve dystonia severity and quality of life in children","volume":"20","author":"Liow","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neurol.2016.07.011_bib0660","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/088307389601100503","article-title":"Antidyskinetic drug therapy for pediatric movement disorders","volume":"11","author":"Pranzatelli","year":"1996","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neurol.2016.07.011_bib0665","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2011-301714","article-title":"Deep brain stimulation for dystonia","volume":"84","author":"Vidailhet","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.011_bib0670","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejpn.2011.12.014","article-title":"Beyond the Burke-Fahn-Marsden Dystonia Rating Scale: deep brain stimulation in childhood secondary dystonia","volume":"16","author":"Gimeno","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neurol.2016.07.011_bib0675","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000323374","article-title":"Bilateral subthalamic nucleus stimulation in the treatment of neurodegeneration with brain iron accumulation type 1","volume":"89","author":"Ge","year":"2011","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.neurol.2016.07.011_bib0680","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3171\/2013.7.PEDS1350","article-title":"Bilateral subthalamic nucleus deep brain stimulation for refractory total body dystonia secondary to metabolic autopallidotomy in a 4-year-old boy with infantile methylmalonic acidemia: case report","volume":"12","author":"Chakraborti","year":"2013","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.neurol.2016.07.011_bib0685","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3171\/2011.8.PEDS11153","article-title":"Deep brain stimulation in children: experience and technical pearls","volume":"8","author":"Air","year":"2011","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.011_bib0690","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3171\/2014.8.PEDS1451","article-title":"Lateralized effect of pallidal stimulation on self-mutilation in Lesch-Nyhan disease","volume":"14","author":"Abel","year":"2014","journal-title":"J Neurosurg Pediatr"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.011_bib0695","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000325703","article-title":"Treatment of homocystinuria-related dystonia with deep brain stimulation: a case report","volume":"89","author":"Aydin","year":"2011","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.011_bib0700","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","article-title":"Treatment of dystonia","volume":"11","author":"Thenganatt","year":"2014","journal-title":"Neurotherapeutics"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716300479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716300479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T01:25:53Z","timestamp":1718760353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716300479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":70,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0035378716300479"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.07.011","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurometabolic disorders are treatable causes of dystonia","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}